Painless eye drops aim to save sight in kids with brain tumors
Disease control
Ongoing
This study tests whether a new, painless form of nerve growth factor (called CHF6467) given as eye drops can protect vision in children and young adults with optic pathway glioma, a type of brain tumor that often causes vision loss. The trial involves 36 participants aged 3 to 40…
Phase: PHASE2 • Sponsor: Benedetto Falsini • Aim: Disease control
Last updated May 01, 2026 16:01 UTC